Biomanufacturing World Summit, November 14-16 at the Hilton San Diego Bayfront
Speed up your development pipeline, achieve faster scale-up and tech transfer and simplify CPV & APQR support, investigations, process optimizations and process monitoring in your manufacturing network.
Enable your digital transformation with SaaS software based on our 30+ years of industry expertise and experience working with 18 of the Top 20 BioPharma companies.
Accelerate process understanding and time-to-insight across your development and manufacturing lifecycle
Come and meet our experts and learn how IDBS’ purpose-built software solutions address the data management challenges prominent across the BioPharma lifecycle and supply chain.
Our cloud-native and analytics-centric Polar BioProcess and PIMS platforms enable customers in development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
PIMS (Process Information Management System)
PIMS helps you improve understanding and control of your manufacturing process. It is 21 CFR Part 11 compliant, cloud-native software that creates a contextualized data backbone of critical manufacturing process and quality data across products and batches. PIMS ensures data visibility and knowledge sharing that is critical to driving fast and effective scale-up and tech transfer.
Polar BioProcess
Polar BioProcess enables you to leverage historical data and knowledge to work smarter and faster in process development. See first-hand how Polar BioProcess digital workflows, integrated instrument and equipment connectors and advanced analytics enable you to accelerate BioPharma development and reduce the time to commercial readiness.
Polar BioProcess comes with Polar Insight AI/ML models, advanced analytics applications and reporting:
- Cell Line Genealogy
- Bioreactor Comparison
- Design of Experiments (DoE)
- Multivariate analysis (MVA)
- Plus the flexibility for you to add your own data models or export data to other packages like Statistica, JMP etc…
We look forward to seeing you there!
Book a meeting
Meet the team
Ken Forman
Senior Director, Product Strategy, IDBS
Ken has over 28 years of experience and expertise in IT, Operations, and Product & Project Management focused in the software and pharmaceutical space.
Prior to joining Skyland Analytics, Ken served as Director, Project Management, NAM at BIOVIA Dassault Systemes and held multiple director positions at Aegis Analytical. Previously, he was Director of IT at Rally Software Development, Director of Commercial Operations at Fischer Imaging and Director of IT at Allos Therapeutics and Genomica. In addition to his work accomplishments, he is a Certified Scrum Master.
Ken holds a BSc in Computer Science from Cal Poly and an MBA from the University of Colorado, Denver.
Marc Smith
Director, Strategic Solutions, IDBS
Marc is accountable for the development of the IDBS Polar BPLM and associated solutions. He is an expert in laboratory and operational technology, laboratory informatics and system integration and leads a team of technological and domain experts committed to the development of the Polar Solutions.
Marc has over 15 years of experience working in the pharmaceutical sector implementing and leading digital solutions and strategies.
Before joining IDBS in 2021, he worked at Lonza Biologics and Angel Biotechnology. He holds a BSc (Hons) in Pharmacology from the University of Sunderland.
Abigail Dyer
Business Development, West Coast, IDBS
Abigail Dyer has over 5 years of experience bringing innovative solutions to the Pharmaceutical, Medical Device and Analytical Testing industries. Her expertise in building strategic partnerships and making business decisions, along with creating the right solutions to address diverse and complex challenges makes her a respected partner in maximizing value and creating pathways to realize improved service and product quality and cultivating relationships.
Prior to IDBS, Abigail held roles at Neodyne Biosciences where she aligned with strategic partners and helped clients define a pathway forward to accelerate technologies for plastic surgery wound care.